TY  - GEN
AU  - Mraz,Marek
AU  - Zent,Clive S
AU  - Church,Amy K
AU  - Jelinek,Diane F
AU  - Wu,Xiaosheng
AU  - Pospisilova,Sarka
AU  - Ansell,Stephen M
AU  - Novak,Anne J
AU  - Kay,Neil E
AU  - Witzig,Thomas E
AU  - Nowakowski,Grzegorz S
TI  - Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
SN  - 1365-2141
PY  - 2014///0509
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - B-Lymphocytes
KW  - Bone Marrow Cells
KW  - physiology
KW  - Cell Adhesion
KW  - Coculture Techniques
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Integrin alpha4beta1
KW  - antagonists & inhibitors
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Natalizumab
KW  - Rituximab
KW  - Stromal Cells
KW  - Tumor Cells, Cultured
KW  - Tumor Microenvironment
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2141.2011.08794.x
ER  -